Form 4 · Filed Jul 6, 2026, 10:09 PM UTC
TAK/TAKEDA PHARMACEUTICAL CO LTD
Miyabashira Asuka — President, Japan Pharma B.U.
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
5 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | D | other | 1,022 | — | — | 0 |
| Jul 1, 2026 | A | other | 1,500 | $0 | — | 4,500 |
| Jul 1, 2026 | A | other | 664 | — | — | 1,392 |
| Jul 1, 2026 | A | other | 664 | — | — | 1,174 |
| Jul 1, 2026 | A | other | 666 | — | — | 666 |
Source: SEC EDGAR raw filing ↗ · Accession 0001395064-26-000261